Sonoma Pharmaceuticals (SNOA) Return on Sales: 2011-2012
Historic Return on Sales for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to -0.30%.
- Sonoma Pharmaceuticals' Return on Sales rose 30.00% to -0.30% in Q4 2012 from the same period last year, while for Dec 2012 it was -0.30%, marking a year-over-year increase of 30.00%. This contributed to the annual value of -0.58% for FY2012, which is 23.00% up from last year.
- Per Sonoma Pharmaceuticals' latest filing, its Return on Sales stood at -0.30% for Q4 2012, which was up 30.17% from -0.42% recorded in Q3 2012.
- Sonoma Pharmaceuticals' Return on Sales' 5-year high stood at -0.30% during Q4 2012, with a 5-year trough of -0.81% in Q1 2011.
- For the 2-year period, Sonoma Pharmaceuticals' Return on Sales averaged around -0.56%, with its median value being -0.58% (2011).
- Data for Sonoma Pharmaceuticals' Return on Sales shows a peak YoY increased of 30bps (in 2012) over the last 5 years.
- Sonoma Pharmaceuticals' Return on Sales (Quarterly) stood at -0.59% in 2011, then climbed by 30bps to -0.30% in 2012.
- Its Return on Sales stands at -0.30% for Q4 2012, versus -0.42% for Q3 2012 and -0.43% for Q2 2012.